E3A Healthcare is transforming women’s health by addressing one of the greatest gaps in medical innovation. We are empowering women and families worldwide with cutting-edge medical devices and AI-driven solutions that expand access, reliability, and impact in healthcare.
Founded in 2019 at the National University of Singapore (NUS), E3A Healthcare leverages advanced expertise in bio-signal processing and biosensor technology to deliver impactful solutions across women’s and newborn health.
To date, E3A have supported over 550,000 families worldwide, helped save hundreds of newborn lives. Backed by world-class Investor including Enterprise Singapore, Hong Kong X Fund and NUS.
We are shaping a future where innovation in women’s health is at the forefront of global progress.
Our Solutions
E3A is dedicated to developing breakthrough medical devices and AI-driven health solutions that tackle the most urgent and unmet needs in women’s healthcare.
Our Partners
Our Investors and Sponsors
Contact Us
We're eager to hear from you! Get in touch with us and let's explore how we can join hands to deliver better care for families worldwide.